Olympic Medical Center
The affiliation between SCCA and Olympic Medical Center means patients living on the Olympic Peninsula have access to the latest cancer treatment options, including those only available in clinical trials or at a comprehensive academic cancer center, such as SCCA.
Below are some of the SCCA clinical trials now being offered for patients at Olympic Medical Center. If you have any questions about these or other trials, please contact Olympic Medical Center.
Breast Cancer (Recurrent/Metastatic)
- Eribulin Mesylate for Previously Treated Metastatic Breast Cancer (8093)
Phase II Trial of Metronomic Eribulin (Halaven) In Pretreated Metastatic Breast Cancer (MBC)
Colon Cancer (Progressive Disease)
A Phase III Clinical Trial Evaluating TheraSphere® in Patients with Metastatic Colorectal Carcinoma of the Liver Who Have Failed First Line Chemotherapy
Gynecologic Cancer (Newly Diagnosed)
- Radiation Therapy Stage I or Stage II Cervical Cancer Post Surgery (GOG 0263)
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy
Gynecologic Cancer (Recurrent/Metastatic)
- Carboplatin + Paclitaxel w/wo Bevacizumab After Surgery (GOG 213)
A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel Alone or in Combination With Bevacizumab (NSC #704865, IND #7921) Followed by Bevacizumab and Secondary Cytoreduction Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer